Cargando…
SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great threat to public health, being a causative pathogen of a deadly coronavirus disease (COVID-19). It has spread to more than 200 countries and infected millions of individuals globally. Although SARS-CoV-2 has structural/genomic s...
Autores principales: | Mehmood, Iqra, Ijaz, Munazza, Ahmad, Sajjad, Ahmed, Temoor, Bari, Amna, Abro, Asma, Allemailem, Khaled S., Almatroudi, Ahmad, Tahir ul Qamar, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915969/ https://www.ncbi.nlm.nih.gov/pubmed/33567746 http://dx.doi.org/10.3390/ijerph18041626 |
Ejemplares similares
-
Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design
por: Ahmad, Sajjad, et al.
Publicado: (2021) -
Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors
por: Alamri, Mubarak A., et al.
Publicado: (2022) -
Towards A Novel Multi-Epitopes Chimeric Vaccine for Simulating Strong Immune Responses and Protection against Morganella morganii
por: Ullah, Asad, et al.
Publicado: (2021) -
Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach
por: Gul, Saba, et al.
Publicado: (2022) -
Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2018)